PRESS RELEASE published on 03/19/2025 at 07:30, 1 year ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
BRIEF published on 01/28/2025 at 07:35, 1 year 1 month ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 1 year 1 month ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 1 month ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 1 month ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 2 months ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour les 12 prochains mois, ouvrant la voie à l'investissement dans les petites et moyennes valeurs en ophtalmologie. Pour plus d'informations, consultez www.nicox.com PEA-PME Investissement Éligibilité Ophtalmologie Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 2 months ago Nicox : Résumé financier et activités du quatrième trimestre 2024 Résultats Financiers Trésorerie Nicox NCX 470 Quatrième Trimestre 2024
BRIEF published on 01/21/2025 at 07:35, 1 year 2 months ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
Published on 03/27/2026 at 08:05, 1 hour 25 minutes ago Battery X Metals Announces Corporate Awareness Engagements
Published on 03/26/2026 at 23:00, 10 hours 30 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 11 hours 25 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 11 hours 30 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 11 hours 30 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/27/2026 at 09:02, 27 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 09:01, 28 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 03/27/2026 at 07:00, 2 hours 30 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 15 hours 13 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 15 hours 13 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 15 hours 30 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
